10 Eyecare Stocks with Upside Potential

In This Article:

In this piece, we will take a look at the ten eyecare stocks with upside potential. For more stocks, head on over to 5 Eyecare Stocks with Upside Potential.

One sector that has massively benefited from the advances in technology is healthcare. In just a century, humans have gone from struggling with basic diseases such as hypertension to combating some of the deadliest diseases known to mankind such as cancer. This growth in the healthcare segment's prowess has also enabled doctors and researchers to make detailed images of complex human body organs such as the eye.

After the brain, the human body's most complex organ is the eye. The eye is capable of discerning a whopping 10 million colors, blinks millions of times each year, have a whopping 100 million rod cells that enable night vision, and the eyes are capable of differentiating between a stunning 500 shades of gray.

At the same time, this complexity of the human eye also leads to a variety of diseases that are different from those faced by the body. After all, while a variety of muscles can spasm, no muscle ever suffered from a cataract. According to the Centers for Disease Control (CDC), 4.2 million Americans are that are older than 40 years are at least legally blind, with the majority of these problems caused by age related macular degeneration. The leading cause of vision loss in the U.S. is cataracts, which, unlike macular degeneration, can occur in individuals falling in any age group. While 4.2 million Americans older than 40 face macular degeneration, a startingly higher number, 20.5 million, suffer from cataracts. In fact, the number of those who have had at least one lens removed due to cataracts sits at 6.1 million - indicating that eye diseases continue to be a big problem in American healthcare.

Eyecare Stocks with Upside Potential
Eyecare Stocks with Upside Potential

Since we're on the topic of cataracts, data from the U.S. National Eye Institute shows that the number of people with cataracts in2050 is estimated to sit at 50 million in 2050 - more than doubling from the 24 million patients in 2010. And where there's a disease, there's a market willing to meet their needs. On this front, data from Healio shows that the cataract surgery industry will grow at a compounded annual growth rate (CAGR) ranging between 3% to 4% for the next three decades. This implies that in a little over two decades there will be approximately eight million cataract surgeries in the U.S., and the research report also adds that should resources allow, then the figure can swell to a whopping 100 million cataract surgeries in a year by 2050. However, while logic would suggest that the growth in surgeries would be accompanied by a growth in surgeons, Healio also adds that in the future, i.e. by 2030, less than 10,000 surgeons will perform 6 million surgeries per year, for roughly 600 surgeries per surgeon per year. This will mark a 200 million growth over the 400 million surgeries that 10,000 surgeons had performed in 2021.